| Ms Rosalie Sematczyn Telwak, R PH | |
|
8001 N Milwaukee Ave, Niles, IL 60714-2801 | |
| (847) 583-0409 | |
| (847) 583-0449 |
| Full Name | Ms Rosalie Sematczyn Telwak |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8001 N Milwaukee Ave, Niles, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104107424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 051.034796 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rosalie Sematczyn Telwak, R PH 10131 Potter Rd, Des Plaines, IL 60016-1546 Ph: (847) 699-6099 | Ms Rosalie Sematczyn Telwak, R PH 8001 N Milwaukee Ave, Niles, IL 60714-2801 Ph: (847) 583-0409 |
News Archive
The ALS Association announced today that it has awarded 21 new research grants totaling nearly $3.5 million to find treatments and a cure for amyotrophic lateral sclerosis (ALS). The grants were awarded to scientists from laboratories located in nine different states in the United States as well as from the United Kingdom, France, Canada, Switzerland, Israel and Australia.
The once-seemingly sure deal, which allowed the Senate to recess for the year, was for a $33 billion package of bills to keep the Social Security tax paid by most workers at 4.2 percent rather than 6.2 percent, extend unemployment benefits for those already receiving them, and avoid reductions in Medicare payments to doctors. The measure would be effective through February.
A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.
Researchers at the Ecole Polytechnique Fédérale de Lausanne have discovered the gene code that sets the pace and order of fetal development.
The multiple sclerosis (MS) therapy alemtuzumab can trigger severe, unpredictable side effects.
› Verified 3 days ago
Joe A Sorisho, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7139 N Milwaukee Ave, Niles, IL 60714 Phone: 847-647-6422 Fax: 847-647-6520 | |
Linda Teichmann, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9000 N Greenwood Ave, Niles, IL 60714 Phone: 847-298-3050 | |
Mustafa Mohammed Ali, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5630 W Touhy Ave, Niles, IL 60714 Phone: 847-647-8683 | |
Dr. Sabina Vakhariya, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8547 N Chester Ave, Niles, IL 60714 Phone: 847-924-2245 | |
Ruby Wilson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8500 W Golf Rd, Niles, IL 60714 Phone: 847-966-9465 | |
Bineesh Moyeed, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 239 Golf Mill Ctr, Niles, IL 60714 Phone: 847-768-9217 |